Expansion of functionally anergic CD21 -/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity

Journal of Immunology

Volumn 187, Issue 12, 2011, Pages 6550-6563

  Terrier, Benjamin ^a,b   Joly, Florence ^c   Vazquez, Thomas ^a   Benech, Philippe ^c   Rosenzwajg, Michelle ^a   Carpentier, Wassila ^b   Garrido, Marlène ^a   Ghillani Dalbin, Pascale ^b   Klatzmann, David ^a   Cacoub, Patrice ^a,b   Saadoun, David ^a,b  

^a Unit of Dermatology   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Prediguard   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CBL PROTEIN; CD19 ANTIGEN; CD1C ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD69 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; EARLY GROWTH RESPONSE FACTOR 2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HERMES ANTIGEN; IMMUNOGLOBULIN M; PROTEIN TYROSINE PHOSPHATASE; TOLL LIKE RECEPTOR 9;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL EXPANSION; CELL SURVIVAL; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; EXCISION REPAIR; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALE; MICROARRAY ANALYSIS; MOLECULAR CLONING; PRIORITY JOURNAL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CLONAL ANERGY; CLONE CELLS; CRYOGLOBULINEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT 3D; SPLEEN;

EID: 83755178490     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102022     Document Type: Article

References (53)

1. Keeffe, E. B. 2001. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 120: 749-762. (Pubitemid 32171644)
2. Agnello, V., R. T. Chung, and L. M. Kaplan. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327: 1490-1495.
3. Hermine, O., F. Lefrère, J. P. Bronowicki, X. Mariette, K. Jondeau, V. Eclache-Saudreau, B. Delmas, F. Valensi, P. Cacoub, C. Brechot, et al. 2002. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347: 89-94. (Pubitemid 34753478)
4. Saadoun, D., F. Suarez, F. Lefrere, F. Valensi, X. Mariette, A. Aouba, C. Besson, B. Varet, X. Troussard, P. Cacoub, and O. Hermine. 2005. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 105: 74-76. (Pubitemid 40053066)
5. Franzin, F., D. G. Efremov, G. Pozzato, P. Tulissi, F. Batista, and O. R. Burrone. 1995. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br. J. Haematol. 90: 548-552.
6. Sansonno, D., S. De Vita, A. R. Iacobelli, V. Cornacchiulo, M. Boiocchi, and F. Dammacco. 1998. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J. Immunol. 160: 3594-3601. (Pubitemid 28164756)
7. Racanelli, V., D. Sansonno, C. Piccoli, F. P. D'Amore, F. A. Tucci, and F. Dammacco. 2001. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J. Immunol. 167: 21-29. (Pubitemid 32567756)
8. Vallat, L., Y. Benhamou, M. Gutierrez, P. Ghillani, C. Hercher, V. Thibault, F. Charlotte, J. C. Piette, T. Poynard, H. Merle-Béral, et al. 2004. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum. 50: 3668-3678. (Pubitemid 39488696)
9. Ivanovski, M., F. Silvestri, G. Pozzato, S. Anand, C. Mazzaro, O. R. Burrone, and D. G. Efremov. 1998. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91: 2433-2442. (Pubitemid 28155518)
10. De Re, V., S. De Vita, A. Marzotto, M. Rupolo, A. Gloghini, B. Pivetta, D. Gasparotto, A. Carbone, and M. Boiocchi. 2000. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96: 3578-3584.
11. Carbonari, M., E. Caprini, T. Tedesco, F. Mazzetta, V. Tocco, M. Casato, G. Russo, and M. Fiorilli. 2005. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J. Immunol. 174: 6532-6539. (Pubitemid 40667522)
12. Charles, E. D., R. M. Green, S. Marukian, A. H. Talal, G. V. Lake-Bakaar, I. M. Jacobson, C. M. Rice, and L. B. Dustin. 2008. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 111: 1344-1356. (Pubitemid 351213421)
13. Knight, G. B., L. Gao, L. Gragnani, M. M. Elfahal, F. G. De Rosa, F. D. Gordon, and V. Agnello. 2010. Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies. Arthritis Rheum. 62: 2152-2159.
14. Chan, C. H., K. G. Hadlock, S. K. Foung, and S. Levy. 2001. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97: 1023-1026. (Pubitemid 32154288)
15. Rosa, D., G. Saletti, E. De Gregorio, F. Zorat, C. Comar, U. D'Oro, S. Nuti, M. Houghton, V. Barnaba, G. Pozzato, and S. Abrignani. 2005. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. USA 102: 18544-18549. (Pubitemid 43011262)
16. Zignego, A. L., F. Giannelli, M. E. Marrocchi, A. Mazzocca, C. Ferri, C. Giannini, M. Monti, P. Caini, G. L. Villa, G. Laffi, and P. Gentilini. 2000. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 31: 474-479. (Pubitemid 30078615)
17. Zuckerman, E., T. Zuckerman, D. Sahar, S. Streichman, D. Attias, E. Sabo, D. Yeshurun, and J. M. Rowe. 2001. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97: 1555-1559. (Pubitemid 32217215)
18. Weller, S., M. C. Braun, B. K. Tan, A. Rosenwald, C. Cordier, M. E. Conley, A. Plebani, D. S. Kumararatne, D. Bonnet, O. Tournilhac, et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654. (Pubitemid 39564441)
19. Wehr, C., H. Eibel, M. Masilamani, H. Illges, M. Schlesier, H. H. Peter, and K. Warnatz. 2004. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113: 161-171. (Pubitemid 39296849)
20. Rakhmanov, M., B. Keller, S. Gutenberger, C. Foerster, M. Hoenig, G. Driessen, M. van der Burg, J. J. van Dongen, E. Wiech, M. Visentini, et al. 2009. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc. Natl. Acad. Sci. USA 106: 13451-13456.
21. Isnardi, I., Y. S. Ng, L. Menard, G. Meyers, D. Saadoun, I. Srdanovic, J. Samuels, J. Berman, J. H. Buckner, C. Cunningham-Rundles, and E. Meffre. 2010. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 115: 5026-5036.
22. Potter, K. N., Y. Li, R. A. Mageed, R. Jefferis, and J. D. Capra. 1999. Molecular characterization of the VH1-specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8. Scand. J. Immunol. 50: 14-20. (Pubitemid 29298021)
23. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453: 667-671. (Pubitemid 351769295)
24. Smith, K., L. Garman, J. Wrammert, N. Y. Zheng, J. D. Capra, R. Ahmed, and P. C. Wilson. 2009. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4: 372-384.
25. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377. (Pubitemid 37075812)
26. Lopez, F., J. Textoris, A. Bergon, G. Didier, E. Remy, S. Granjeaud, J. Imbert, C. Nguyen, and D. Puthier. 2008. TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus database. PLoS One 3: e4001.
27. Wrammert, J., D. Koutsonanos, G. M. Li, S. Edupuganti, J. Sui, M. Morrissey, M. McCausland, I. Skountzou, M. Hornig, W. I. Lipkin, et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208: 181-193.
28. Dinkel, A., K. Warnatz, B. Ledermann, A. Rolink, P. F. Zipfel, K. Bürki, and H. Eibel. 1998. The transcription factor early growth response 1 (Egr-1) advances differentiation of pre-B and immature B cells. J. Exp. Med. 188: 2215-2224. (Pubitemid 29028494)
29. Kim, J. S., D. W. Park, H. K. Lee, J. R. Kim, and S. H. Baek. 2009. Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9-MyD88-ERK1/2 pathway. Biochem. Biophys. Res. Commun. 390: 196-200.
30. Maltzman, J. S., J. A. Carman, and J. G. Monroe. 1996. Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16: 2283-2294. (Pubitemid 26123749)
31. Li, D. H., M. M. Winslow, T. M. Cao, A. H. Chen, C. R. Davis, E. D. Mellins, P. J. Utz, G. R. Crabtree, and J. R. Parnes. 2008. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum. 58: 3192-3204.
32. Zheng, Y., Y. Zha, and T. F. Gajewski. 2008. Molecular regulation of T-cell anergy. EMBO Rep. 9: 50-55.
33. Saeki, K., Y. Miura, D. Aki, T. Kurosaki, and A. Yoshimura. 2003. The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J. 22: 3015-3026. (Pubitemid 36758622)
34. Higgs, M. R., H. Lerat, and J. M. Pawlotsky. 2010. Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res. 70: 4901-4911.
35. Kondo, Y., K. Machida, H. M. Liu, Y. Ueno, K. Kobayashi, T. Wakita, T. Shimosegawa, and M. M. Lai. 2009. Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. J. Infect. Dis. 199: 726-736.
36. Hartley, S. B., J. Crosbie, R. Brink, A. B. Kantor, A. Basten, and C. C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353: 765-769. (Pubitemid 21912617)
37. Gauld, S. B., R. J. Benschop, K. T. Merrell, and J. C. Cambier. 2005. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat. Immunol. 6: 1160-1167. (Pubitemid 41541794)
38. Cambier, J. C., S. B. Gauld, K. T. Merrell, and B. J. Vilen. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7: 633-643. (Pubitemid 47123549)
39. Moir, S., J. Ho, A. Malaspina, W. Wang, A. C. DiPoto, M. A. O'Shea, G. Roby, S. Kottilil, J. Arthos, M. A. Proschan, et al. 2008. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 205: 1797-1805.
40. Landau, D. A., M. Rosenzwajg, D. Saadoun, D. Klatzmann, and P. Cacoub. 2009. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders. Ann. Rheum. Dis. 68: 337-344.
41. Duty, J. A., P. Szodoray, N. Y. Zheng, K. A. Koelsch, Q. Zhang, M. Swiatkowski, M. Mathias, L. Garman, C. Helms, B. Nakken, et al. 2009. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J. Exp. Med. 206: 139-151.
42. Quách, T. D., N. Manjarrez-Orduño, D. G. Adlowitz, L. Silver, H. Yang, C. Wei, E. C. Milner, and I. Sanz. 2011. Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J. Immunol. 186: 4640-4648.
43. Guo, L., J. Tian, Z. Guo, B. Zheng, and S. Han. 2011. The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoantibodies and exacerbates glomerulonephritis in murine lupus. Clin. Exp. Immunol. 164: 227-235.
44. Cappione, A., III, J. H. Anolik, A. Pugh-Bernard, J. Barnard, P. Dutcher, G. Silverman, and I. Sanz. 2005. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115: 3205-3216. (Pubitemid 41567585)
45. Harris, J. E., K. D. Bishop, N. E. Phillips, J. P. Mordes, D. L. Greiner, A. A. Rossini, and M. P. Czech. 2004. Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells. J. Immunol. 173: 7331-7338. (Pubitemid 39628171)
46. Safford, M., S. Collins, M. A. Lutz, A. Allen, C. T. Huang, J. Kowalski, A.Blackford, M.R. Horton,C. Drake,R. H. Schwartz, and J. D. Powell. 2005. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 6: 472-480. (Pubitemid 41716760)
47. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607. (Pubitemid 34406754)
48. Charles, E. D., C. Brunetti, S. Marukian, K. D. Ritola, A. H. Talal, K. Marks, I. M. Jacobson, C. M. Rice, and L. B. Dustin. 2011. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood 117: 5425-5437.
49. Zignego, A. L., C. Ferri, F. Giannelli, C. Giannini, P. Caini, M. Monti, M. E. Marrocchi, E. Di Pietro, G. La Villa, G. Laffi, and P. Gentilini. 2002. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann. Intern. Med. 137: 571-580.
50. Kitay-Cohen, Y., A. Amiel, N. Hilzenrat, D. Buskila, Y. Ashur, M. Fejgin, E. Gaber, R. Safadi, R. Tur-Kaspa, and M. Lishner. 2000. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96: 2910-2912.
51. Koelsch, K., N.-Y. Zheng, Q. Zhang, A. Duty, C. Helms, M. D. Mathias, M. Jared, K. Smith, J. D. Capra, and P. C. Wilson. 2007. Mature B cells class switched to IgD are autoreactive in healthy individuals. J. Clin. Invest. 117: 1558-1565. (Pubitemid 46871340)
52. Zheng, N. Y., K. Wilson, M. Jared, and P. C. Wilson. 2005. Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation. J. Exp. Med. 201: 1467-1478. (Pubitemid 40664090)
53. Zheng, N. Y., K. Wilson, X. Wang, A. Boston, G. Kolar, S. M. Jackson, Y. J. Liu, V. Pascual, J. D. Capra, and P. C. Wilson. 2004. Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. J. Clin. Invest. 113: 1188-1201. (Pubitemid 38544104)